Xenon Pharmaceuticals (XENE) Institutional Ownership $32.26 +0.10 (+0.31%) Closing price 06/11/2025 04:00 PM EasternExtended Trading$32.29 +0.03 (+0.09%) As of 06/11/2025 05:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Xenon Pharmaceuticals (NASDAQ:XENE)CurrentInstitutional OwnershipPercentage95.45%Number ofInstitutional Buyers(last 12 months)110TotalInstitutional Inflows(last 12 months)$443.54MNumber ofInstitutional Sellers(last 12 months)80TotalInstitutional Outflows(last 12 months)$272.96M Get XENE Insider Trade Alerts Want to know when executives and insiders are buying or selling Xenon Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data XENE Institutional Buying and Selling by Quarter Xenon Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/19/2025 UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC63,568$2.13M0.0%-66.9%0.083% 5/16/2025 Goldman Sachs Group Inc.442,732$14.85M0.0%+7.9%0.578% 5/16/2025 Samlyn Capital LLC1,016,381$34.10M0.5%-0.1%1.327% 5/16/2025 Parkman Healthcare Partners LLC174,576$5.86M0.7%-9.5%0.228% 5/16/2025 Millennium Management LLC234,056$7.85M0.0%-32.4%0.306% 5/16/2025 Granahan Investment Management LLC183,808$6.17M0.3%+0.8%0.240% 5/16/2025 Alliancebernstein L.P.1,329,386$44.60M0.0%-7.9%1.736% 5/16/2025 Advisors Asset Management Inc.14,281$479K0.0%+9.4%0.019% 5/16/2025 Ally Bridge Group NY LLC69,603$2.34M2.1%-46.2%0.091% 5/16/2025 Alyeska Investment Group L.P.367,233$12.32M0.0%+27.1%0.479% Get the Latest News and Ratings for XENE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Xenon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 5/16/2025 Adage Capital Partners GP L.L.C.1,914,749$64.24M0.1%+2.8%2.500% 5/16/2025 ADAR1 Capital Management LLC127,548$4.28M0.8%+152.3%0.167% 5/15/2025 First Light Asset Management LLC627,904$21.07M2.4%-45.9%0.820% 5/15/2025 Vestal Point Capital LP1,300,000$43.62M3.1%+60.5%1.697% 5/15/2025 Birchview Capital LP21,000$705K0.6%+110.0%0.027% 5/15/2025 MPM Bioimpact LLC303,398$10.18M1.7%+53.8%0.396% 5/15/2025 Baker BROS. Advisors LP347,408$11.66M0.1%-65.0%0.454% 5/15/2025 Braidwell LP2,709,875$90.92M3.2%-7.0%3.538% 5/15/2025 Royal Bank of Canada59,366$1.99M0.0%-1.2%0.078% 5/15/2025 Vident Advisory LLC6,574$221K0.0%+21.4%0.009% 5/15/2025 Driehaus Capital Management LLC4,584,859$153.82M1.5%+1.4%5.986% 5/15/2025 Siren L.L.C.732,761$24.58M1.4%-1.5%0.955% 5/14/2025 Affinity Asset Advisors LLC1,328,175$44.56M4.3%+14.4%1.734% 5/14/2025 Atika Capital Management LLC24,000$805K0.1%-66.9%0.031% 5/14/2025 Candriam S.C.A.454,650$15.25M0.1%-7.6%0.594% 5/14/2025 T. Rowe Price Investment Management Inc.796,986$26.74M0.0%-44.6%1.041% 5/14/2025 EntryPoint Capital LLC8,872$298K0.1%N/A0.012% 5/14/2025 Wellington Management Group LLP3,789,197$127.13M0.0%+0.3%4.947% 5/13/2025 Algert Global LLC123,415$4.14M0.1%-48.9%0.161% 5/13/2025 Aberdeen Group plc404,154$13.56M0.0%+42.4%0.528% 5/13/2025 Fox Run Management L.L.C.11,372$382K0.1%+31.9%0.015% 5/13/2025 Lord Abbett & CO. LLC87,981$2.95M0.0%-54.9%0.115% 5/13/2025 Caitong International Asset Management Co. Ltd905$30K0.0%N/A0.001% 5/13/2025 Russell Investments Group Ltd.75,341$2.53M0.0%-64.7%0.098% 5/12/2025 Knott David M Jr15,866$532K0.3%-24.0%0.021% 5/12/2025 Invesco Ltd.205,763$6.90M0.0%-1.8%0.269% 5/12/2025 Swiss National Bank125,600$4.21M0.0%-0.8%0.164% 5/9/2025 Mutual of America Capital Management LLC48,763$1.64M0.0%N/A0.064% 5/9/2025 CenterBook Partners LP22,211$745K0.0%N/A0.029% 5/9/2025 Westfield Capital Management Co. LP1,391,370$46.68M0.2%+20.2%1.817% Trump set to Boost Social Security Checks by 400%? (Ad)If you're collecting or planning to collect social security... You should see this presentation about President Trump's Executive Order #14196. Legendary investor Louis Navellier believes it could soon not only save Social Security from collapse... But BOOST benefits for millions of retirees by up to 400%. No wonder the financial times called this new initiative...Click here to see the details because the stakes couldn't be any higher.5/9/2025 BIT Capital GmbH17,352$582K0.0%-67.8%0.023% 5/9/2025 J. Safra Sarasin Holding AG30,573$1.03M0.0%+71.9%0.040% 5/8/2025 Natixis Advisors LLC24,010$806K0.0%+1.9%0.031% 5/8/2025 Federated Hermes Inc.232,500$7.80M0.0%-58.4%0.304% 5/7/2025 Fiera Capital Corp529,442$17.76M0.1%-1.2%0.691% 5/7/2025 Zurcher Kantonalbank Zurich Cantonalbank 18,956$636K0.0%-1.6%0.025% 5/7/2025 Skandinaviska Enskilda Banken AB publ 47,457$1.59M0.0%+17.5%0.062% 5/6/2025 Assetmark Inc.19,934$669K0.0%-7.6%0.026% 5/6/2025 Legato Capital Management LLC9,622$323K0.0%N/A0.013% 5/6/2025 Y Intercept Hong Kong Ltd11,949$401K0.0%N/A0.016% 5/5/2025 Allianz Asset Management GmbH9,400$315K0.0%-24.2%0.012% 5/5/2025 Jennison Associates LLC776,693$26.06M0.0%-3.1%1.014% 5/2/2025 TimesSquare Capital Management LLC745,551$25.01M0.4%-12.2%0.974% 5/1/2025 New York State Common Retirement Fund142,372$4.78M0.0%+7.4%0.186% 5/1/2025 Mutual of America Capital Management LLC48,763$1.64M0.0%N/A0.064% 4/30/2025 Alps Advisors Inc.55,332$1.86M0.0%-10.2%0.072% 4/30/2025 China Universal Asset Management Co. Ltd.15,353$515K0.0%-5.0%0.020% 4/29/2025 Envestnet Asset Management Inc.42,850$1.44M0.0%-9.4%0.056% 4/29/2025 Bank of New York Mellon Corp251,147$8.43M0.0%+439.0%0.328% 4/29/2025 GF Fund Management CO. LTD.1,952$65K0.0%+21.9%0.003% 4/28/2025 Teacher Retirement System of Texas17,439$585K0.0%-8.6%0.023% 4/15/2025 Assenagon Asset Management S.A.241,206$8.09M0.0%+1.1%0.315% 4/15/2025 SG Americas Securities LLC8,655$290K0.0%-34.9%0.011% 4/14/2025 Harbor Capital Advisors Inc.56,591$1.90M0.1%+13.6%0.074% 3/18/2025 California State Teachers Retirement System55,492$2.18M0.0%-0.9%0.072% 2/19/2025 GF Fund Management CO. LTD.1,601$63K0.0%N/A0.002% 2/17/2025 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC191,852$7.52M0.0%+17.9%0.252% 2/17/2025 Woodline Partners LP39,938$1.57M0.0%N/A0.052% 2/17/2025 Vestal Point Capital LP810,000$31.75M1.9%-1.8%1.062% 2/17/2025 Vident Advisory LLC5,413$212K0.0%N/A0.007% 2/17/2025 Squarepoint Ops LLC6,554$257K0.0%-12.7%0.009% 2/17/2025 Two Sigma Advisers LP298,700$11.71M0.0%+9.1%0.392% 2/17/2025 Two Sigma Investments LP273,352$10.72M0.0%+12.2%0.359% 2/17/2025 Tema Etfs LLC6,111$240K0.1%N/A0.008% 2/17/2025 Stempoint Capital LP375,845$14.73M3.7%N/A0.493% 2/17/2025 Sphera Funds Management LTD.52,097$2.04M0.4%N/A0.068% 2/17/2025 Polar Capital Holdings Plc2,697,657$105.75M0.6%+10.3%3.538% 2/17/2025 MPM Bioimpact LLC197,212$7.73M1.1%+18.9%0.259% 2/17/2025 Parkman Healthcare Partners LLC193,004$7.57M1.0%+0.7%0.253% 2/17/2025 Occudo Quantitative Strategies LP11,441$448K0.1%+5.8%0.015% 2/17/2025 Orbimed Advisors LLC947,877$37.16M0.8%+4.0%1.243% 2/17/2025 Millennium Management LLC346,040$13.57M0.0%+65.5%0.454% 2/17/2025 Janus Henderson Group PLC2,866,755$112.43M0.1%+12.3%3.760% 2/17/2025 Granahan Investment Management LLC182,333$7.15M0.3%-9.2%0.239% 2/17/2025 Ensign Peak Advisors Inc26,094$1.02M0.0%-84.0%0.034% 2/17/2025 D. E. Shaw & Co. Inc.86,973$3.41M0.0%-57.6%0.114% 2/17/2025 Driehaus Capital Management LLC4,520,595$177.21M1.5%-1.6%5.929% 2/17/2025 Deep Track Capital LP169,132$6.63M0.2%N/A0.222% 2/17/2025 Braidwell LP2,913,964$114.23M3.4%+7.6%3.822% 2/17/2025 Brevan Howard Capital Management LP19,005$745K0.0%+58.2%0.025% Trump set to Boost Social Security Checks by 400%? (Ad)If you're collecting or planning to collect social security... You should see this presentation about President Trump's Executive Order #14196. Legendary investor Louis Navellier believes it could soon not only save Social Security from collapse... But BOOST benefits for millions of retirees by up to 400%. No wonder the financial times called this new initiative...Click here to see the details because the stakes couldn't be any higher.2/17/2025 Avidity Partners Management LP474,000$18.58M1.8%-42.1%0.622% 2/17/2025 Balyasny Asset Management L.P.184,580$7.24M0.0%+119.2%0.242% 2/17/2025 Bank of America Corp DE106,906$4.19M0.0%-16.1%0.140% 2/17/2025 Ameriprise Financial Inc.92,350$3.62M0.0%+39.1%0.121% 2/17/2025 Algert Global LLC241,417$9.46M0.2%+9.9%0.317% 2/17/2025 AXA S.A.187,796$7.36M0.0%-0.2%0.246% 2/17/2025 Allostery Investments LP30,000$1.18M1.2%N/A0.039% 2/17/2025 Ally Bridge Group NY LLC129,291$5.07M4.3%-39.0%0.170% 2/14/2025 Boxer Capital Management LLC600,000$23.52M2.0%N/A0.787% 2/14/2025 Schonfeld Strategic Advisors LLC15,150$594K0.0%+11.5%0.020% (Data available from 1/1/2016 forward) XENE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of XENE shares? During the previous two years, 196 institutional investors and hedge funds held shares of Xenon Pharmaceuticals. The most heavily invested institutionals were FMR LLC ($294.99M), Avoro Capital Advisors LLC ($261.01M), Driehaus Capital Management LLC ($153.82M), Wellington Management Group LLP ($127.13M), Janus Henderson Group PLC ($112.43M), Polar Capital Holdings Plc ($105.75M), and Capital International Investors ($99.85M).Learn more on XENE's institutional investors. What percentage of Xenon Pharmaceuticals stock is owned by institutional investors? 95.45% of Xenon Pharmaceuticals stock is owned by institutional investors. Learn more on XENE's institutional investor holdings. Which institutional investors have been buying Xenon Pharmaceuticals stock? Of the 162 institutional investors that purchased Xenon Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Polar Capital Holdings Plc ($3.28M), Wellington Management Group LLP ($3.14M), Janus Henderson Group PLC ($1.82M), JPMorgan Chase & Co. ($1.29M), Affinity Asset Advisors LLC ($1.12M), First Light Asset Management LLC ($1.04M), and Vestal Point Capital LP ($965K). How much institutional buying is happening at Xenon Pharmaceuticals? Institutional investors have bought a total of 29,208,241 shares in the last 24 months. This purchase volume represents approximately $1.19B in transactions. Which Xenon Pharmaceuticals major shareholders have been selling company stock? Of the 97 institutional investors that sold Xenon Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Braidwell LP ($968.93K), BVF Inc. IL ($937.89K), FMR LLC ($935.84K), Lord Abbett & CO. LLC ($932.41K), Perceptive Advisors LLC ($917.75K), First Light Asset Management LLC ($892.99K), and Nicholas Investment Partners LP ($766.70K). How much institutional selling is happening at Xenon Pharmaceuticals? Institutional investors have sold a total of 14,077,782 shares in the last 24 months. This volume of shares sold represents approximately $534.00M in transactions. Related Companies Blueprint Medicines Major Shareholders Roivant Sciences Major Shareholders Revolution Medicines Major Shareholders Verona Pharma Major Shareholders BridgeBio Pharma Major Shareholders Elanco Animal Health Major Shareholders Grifols Major Shareholders Telix Pharmaceuticals Limited American Depositary Shares Major Shareholders TG Therapeutics Major Shareholders Nuvalent Major Shareholders This page (NASDAQ:XENE) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xenon Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Xenon Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.